Medical management of Cushing's disease (Q38154515)

29 August 2017

Medical management of Cushing's disease (English)

1 reference

29 August 2017

Nicholas A Tritos

1

1 reference

PubMed ID

24146187

29 August 2017

Beverly M K Biller

series ordinal

2

1 reference

29 August 2017

22 October 2013

1 reference

Journal of Neuro-Oncology

29 August 2017

1 reference

29 August 2017

117

1 reference

29 August 2017

3

1 reference

29 August 2017

407-414

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-013-1269-1

29 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Management of Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Long-term mortality after transsphenoidal surgery for Cushing disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Late recurrences of Cushing's disease after initial successful transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Approach to the Cushing's disease patient with persistent/recurrent hypercortisolism after pituitary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Management of recurrent Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

ACTH-producing tumor of the pituitary gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Cushing's Syndrome: important issues in diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Clinical practice. Prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Cabergoline monotherapy in the long-term treatment of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Dopamine agonists and the risk of cardiac-valve regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Clinical Review#: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Valvular heart disease and the use of dopamine agonists for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Update in the medical therapy of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Therapy of Cushing's syndrome with steroid biosynthesis inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Acute hypoadrenalism and hepatotoxicity after treatment with ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Treatment of Cushing's disease by O,p'DDD. Survey of 62 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-013-1269-1

Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas

21 January 2018

1 reference

12 December 2020

Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome

1 reference

12 December 2020

Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome

1 reference

12 December 2020

The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease

1 reference

12 December 2020

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

1 reference

12 December 2020

Advances in medical therapies for Cushing's syndrome.

1 reference

12 December 2020

Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome

1 reference

12 December 2020

Risk factors and long-term outcome in pituitary-dependent Cushing's disease

1 reference

12 December 2020

Case records of the Massachusetts General Hospital. Case 40-2011. A 52-year-old man with weakness, infections, and enlarged adrenal glands

1 reference

12 December 2020

Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group

1 reference

12 December 2020

Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers

1 reference

12 December 2020

Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome

1 reference

12 December 2020

10.1007/S11060-013-1269-1

Identifiers

DOI

1 reference

PubMed ID

24146187

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24146187